| Date | Form | Description | Docs | XBRL | Pages |
| 07/20/20 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material |
|
3 | |
| 07/02/20 | DEF 14A | Definitive proxy statements |
|
46 | |
| 07/02/20 | 8-K | Current report filing |
|
6 | |
| 06/22/20 | PRE 14A | Preliminary proxy statement not related to a contested matter or merger/acquisition |
|
46 | |
| 06/17/20 | 4 | Statement of changes in beneficial ownership of securities |
|
2 | |
| 06/16/20 | 4 | Statement of changes in beneficial ownership of securities |
|
2 | |
| 06/12/20 | 4 | Statement of changes in beneficial ownership of securities |
|
2 | |
| 06/09/20 | 10-Q | Quarterly report pursuant to Section 13 or 15(d) |
|
|
60 |
| 05/04/20 | 4 | Statement of changes in beneficial ownership of securities |
|
2 | |
| 04/20/20 | 8-K | Current report filing |
|
3 |
Latest News & Events
Anixa Biosciences Breast Cancer Vaccine Technology Nearing FDA Submission
Read More...Anixa Biosciences Announces Change to Virtual Format for 2020 Annual Meeting of Stockholders
Read More...Anixa Biosciences' CAR-T Cancer Therapy Receives Intention to Grant Notice from the European Patent Office
Read More...